CIX3 used in HER2-positive Tumor Research

September 14, 2022

See what researchers found in the recent study: Enhancement of antitumor immune response by radiation therapy combined with dual immune checkpoint inhibitor in a  metastatic model of HER2‑positive murine tumor. See the original publication here.



Contact Us

Find out more about how Xstrahl will work tirelessly for you

Explore Related Posts